Authors
Latest:
The ins and outs of gene therapy for inherited optic neuropathiesA look at what’s in the therapeutic delivery pipeline for these disorders.
Latest:
Onboarding a new trifocal hydrophobic C-loop IOL My early experiences with AT ELANA® 841P from ZEISSDiabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.
Latest:
Hemorrhagic unilateral retinopathy: No proven aetiology for rare conditionMultimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages
Latest:
Code-free deep learning: The next phase of AI-enabled healthcare?Code-free deep learning models are expected to find applications across a range of areas to improve patient care, increase accessibility to healthcare, accelerate clinical research and enhance medical education.
Latest:
Tried and tested therapeutic options for meibomian gland dysfunctionMethods using a combination of non-invasive thermal treatments and meibomian gland expression seem to be particularly effective.
Latest:
Examining the stability of a new aspheric IOL in cataract patientsA new monofocal IOL was found to provide stability in the capsular bag 1 week and 1 month after implantation, with good refractive outcomes.
Latest:
Untangling the genetic secrets of retinoblastomaIdentifying all genetic culprits may improve diagnostics and prognoses
Latest:
Investigators explore pathogenic cytokines as biomarkers for DMOResults of a study analysing cytokine levels in the aqueous humour and serum of patients with nonproliferative diabetic retinopathy with and without diabetic macular oedema support further research investigating transforming growth factor-β-induced Gene Human Clone 30 (BIGH3) as a potential biomarker for DMO.
Latest:
Machine learning: A view from new anglesMore testing is needed to ensure accuracy across different groups
Latest:
Rayaz Malik, MBChB, PhD: The bold future of imaging lies in the anterior segmentIn the second of two video interviews from the International SPECTRALIS Symposium, Prof Malik emphasises the importance of corneal imaging
Latest:
Impact of Durable Therapies on Patients and Clinics and Monitoring StrategiesPanelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.
Latest:
In-home Accustat vision test: Equivalent results to in-office Snellen measurementsInvestigators emphasised a significant unmet need for home-based monitoring of visual function with patient-centric technologies
Latest:
Efficiency of physiotherapy in treating and preventing uncomplicated acquired myopiaPatients underwent electropuncture, low-intensity laser stimulation of the ciliary muscle, combined therapy and optical-reflex treatment of accommodation
Latest:
UNCOVERING HIDDEN PREDATORS IN DISEASEThis article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.
Latest:
Maintaining quality and safety in retina clinics during a pandemicTo maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimise clinic visits and maximise use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximising safety and patients’ vision outcomes.
Latest:
Cataract predictability: Screen and treat unstable tear film in weeksCorrecting abnormal tear film osmolarity before cataract surgery enables more accurate measurements to be captured, reducing residual refractive error.
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
French OPHTAMYOP study reveals trends in myopia controlHow studies into myopia management can increase access to vision care
Latest:
New therapeutic targets, drug development for retinitis pigmentosaSimply slowing disease progression is no longer enough
Latest:
What innovation means for the treatment of corneal dystrophiesPhysician outlines latest emerging technologies to treat condition
Latest:
Fortified antibiotic advance improves corneal infection treatment paradigmNo two corneal ulcers are alike, but if they are large and centrally located, the common denominator is that time is of the essence
Latest:
Tried and tested therapeutic options for meibomian gland dysfunctionMethods using a combination of non-invasive thermal treatments and meibomian gland expression seem to be particularly effective.
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Latest:
Retinal imaging to detect Alzheimer disease: machine learning modelAn interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Latest:
No toric? No problem: Small-aperture optics can mitigate astigmatismA one-piece, hydrophobic, monofocal IOL uses the small-aperture concept to provide a good alternative to the toric IOLs currently available.
Latest:
Myopia’s global impact, by the numbersThe global prevalence of myopia has surged, and is expected to affect nearly 5 billion people by 2050
